Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
Peter Bager, Jan Wohlfahrt, Samir Bhatt, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. 967-976
Open Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 937
Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California
Joseph A. Lewnard, Vennis Hong, Manish M. Patel, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1933-1943
Open Access | Times Cited: 321
The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity
Yongbing Zhou, Hui‐Lin Zhi, Yong Teng
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 132
Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark
Christian Holm Hansen, Nikolaj Ulrik Friis, Peter Bager, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 2, pp. 167-176
Open Access | Times Cited: 98
Clinical outcomes associated with Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in southern California
Joseph A. Lewnard, Vennis Hong, Manish M. Patel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 81
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform
Bang Zheng, Amelia Green, John Tazare, et al.
BMJ (2022), pp. e071932-e071932
Open Access | Times Cited: 75
Risk of reinfection and disease after SARS‐CoV‐2 primary infection: Meta‐analysis
Maria Elena Flacco, Cecilia Acuti Martellucci, Valentina Baccolini, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 10
Open Access | Times Cited: 74
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019–positive patients
Feihong Hu, Yijie Jia, Dan‐Yan Zhao, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 7, pp. 835-844
Open Access | Times Cited: 56
Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis
Pryanka Relan, Nkengafac Villyen Motaze, Kavita Kothari, et al.
BMJ Global Health (2023) Vol. 8, Iss. 7, pp. e012328-e012328
Open Access | Times Cited: 49
The role of immune activation and antigen persistence in acute and long COVID
Skye Opsteen, Jacob K. Files, Tim Fram, et al.
Journal of Investigative Medicine (2023) Vol. 71, Iss. 5, pp. 545-562
Open Access | Times Cited: 40
Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
Robert Flisiak, Piotr Rzymski, Dorota Zarębska‐Michaluk, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 149-149
Open Access | Times Cited: 38
Delta and Omicron SARS-CoV-2 pneumonia: Comparison of clinical and radiological features
Jonathan Pehlivan, Pierre Berge, Anne-Laurence Gourdier, et al.
Infectious Diseases Now (2025), pp. 105026-105026
Open Access | Times Cited: 1
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 56
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience
Giusy Tiseo, Chiara Barbieri, Valentina Galfo, et al.
Infectious Diseases and Therapy (2022) Vol. 12, Iss. 1, pp. 257-271
Open Access | Times Cited: 43
Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)
Daniele Petrone, Alberto Mateo‐Urdiales, Chiara Sacco, et al.
International Journal of Infectious Diseases (2023) Vol. 129, pp. 135-141
Open Access | Times Cited: 34
Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study
Sho Nakakubo, Naoki Kishida, Kenichi Okuda, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 11, pp. 1244-1256
Open Access | Times Cited: 30
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
Laura Pérez‐Alós, Cecilie Bo Hansen, José Juan Almagro Armenteros, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
T cell immune memory after covid-19 and vaccination
Lulu Wang, Alexander R. Nicols, Lance Turtle, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000468-e000468
Open Access | Times Cited: 25
Bias in vaccine effectiveness studies of clinically severe outcomes that are measured with low specificity: the example of COVID-19-related hospitalisation
Christian Holm Hansen
Eurosurveillance (2024) Vol. 29, Iss. 7
Open Access | Times Cited: 9
Epidemiology of 7375 children and adolescents hospitalized with COVID-19 in Germany, reported via a prospective, nationwide surveillance study in 2020–2022
Maren Doenhardt, Markus Hufnagel, Natalie Diffloth, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
Hermaleigh Townsley, Joshua Gahir, Timothy Russell, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0294897-e0294897
Open Access | Times Cited: 7
COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis
Maria Elena Flacco, Cecilia Acuti Martellucci, Valentina Baccolini, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 35
Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation—A Danish nationwide cohort study
Maria Overvad, Anders Koch, Bente Jespersen, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 11, pp. 2627-2636
Open Access | Times Cited: 34
SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6272-6272
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top